EPIQ PARTNERS, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
EPIQ PARTNERS, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,145,000
-20.5%
1,301,350
+12.1%
0.70%
-9.4%
Q1 2022$1,440,000
-26.3%
1,161,350
+15.9%
0.77%
-25.7%
Q4 2021$1,955,000
-22.1%
1,002,350
+9.4%
1.04%
-9.9%
Q3 2021$2,510,000
-14.6%
916,100
-1.8%
1.16%
-21.4%
Q2 2021$2,939,000
+56.4%
932,956
+5.8%
1.47%
+36.9%
Q1 2021$1,879,000881,9561.08%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders